UroToday.com - This a randomized, double-blind, placebo controlled, parallel group, multicenter study involving 200 men with or without erectile dysfunction. Men (25-64 years of age) did not have ejaculatory dysfunction. Subjects were randomized to daily treatment with vardenafil, sildenafil or placebo for Read more…
Pfizer’s Lyrica reduced pain of fibromyalgia in patients regardless of whether they experienced symptoms of anxiety or depression at the beginning of the study, according to a pooled analysis presented today at the American Academy of Neurology annual meeting. The analysis, which looked at data pooled from previous clinical trials, also showed that patients’ self-reported improvements were more closely associated with improvements Read more…
A randomized controlled trial by Lyon investigators discloses the difficulties in treating chronic posttraumatic stress disorder with psychotherapy in the March issue of Psychotherapy and Psychosomatics.
To date, there have been no studies comparing cognitive behavior therapy (CBT) with Rogerian therapy in post-traumatic stress disorder. In Read more…
Over five million of the 13 million hay fever sufferers across Britain could be taking
inappropriate medicines, putting their health at risk. The Royal Pharmaceutical Society of
(RPSGB) is encouraging people experiencing the symptoms of hay fever to visit
their community pharmacist after new research revealed that the public often misdiagnose the
condition and fail to get the correct treatment.
Allergic rhinitis, known as hay fever, is a condition which is Read more…
NeuroInvestment announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly aversive side effects for the majority. With millions of patients going untreated Read more…
The U.S. Food and Drug Administration requested that SEI Pharmaceuticals, of Miami, Fla., recall all Xiadafil VIP Tabs sold in 8 tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect a person’s blood pressure and can cause other life-threatening side effects. These lots of Xiadafil Read more…
For people with diabetes, high blood pressure poses a special threat, multiplying their risk of heart attacks, strokes and kidney problems.
But a new study finds that even when people with diabetes show up in their doctor’s office with a high blood pressure reading, there’s only a 50-50 chance that each of them will get some sort of attention for it. That might mean a change to their medications, or a plan to follow Read more…
Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that Read more…
Buy amoxil pills Many people use "alternative" or complementary products because they see them as a more gentle form of medicine. The German Institute for Quality and Efficiency in Health Care has now analysed the latest research on several products Read more…
Infants and toddlers whose mothers are severely depressed are almost three times more likely to suffer accidental injuries than other children in the same age group, according to a new study. The study’s findings, published in the Advanced Access edition of the Journal of Pediatric Psychology, suggest that proper treatment for depression would improve not only the mothers’ health, but the health of young children Read more…
Buy cipro pills The House of Lords will on Thursday 8 May debate the Science and Technology Committee’s report on Allergy which was published in September Read more…
A study published in the latest issue of Hypertension demonstrates that the leading angiotensin receptor blocker (ARB) Diovan® (valsartan) in combination with the diuretic hydrochlorothiazide (HCT) improves artery elasticity (i.e. reduces stiffness), a sign of artery ageing, in patients with type 2 diabetes, high blood pressure and kidney disease compared to those taking another widely-used high blood pressure Read more…
May is Hypertension Awareness Month, and a new device in high blood pressure clinical trials is showing promise for treating U.S. hypertension (high blood pressure) patients whose condition is not controlled by drugs. Rheos® Hypertension (HT) Therapy is an implantable device designed to lower high blood pressure - the number Read more…
Men’s Health News
Generic lexapro pills no prescription A comprehensive re-evaluation of the largest prostate cancer prevention study ever completed produced new findings suggesting that men and their doctors should consider a more aggressive approach that includes finasteride to prevent the development of prostate Read more…
Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR) did not meet its primary endpoint.
"Our analysis of the overall data in this program and the current competitive environment in allergic rhinitis indicate that epinastine nasal spray does not show potential to meet our desired product profile in the United States," Read more…
Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented at the American College of Cardiology in Read more…
Nearly 20 percent of military service members who have returned from Iraq and Afghanistan — 300,000 in all — report symptoms of post traumatic stress disorder or major depression, yet only slight more than half have sought treatment, according to a new RAND Corporation study.
In addition, researchers found about 19 percent of returning service members report that they experienced a possible traumatic brain injury while deployed, with 7 percent reporting Read more…
The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction (ED), provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology.
EHS Read more…
Is medicated memory manipulation ethically sound? Buy generic soma And perhaps more importantly, who should be charged with the decision to deliver such a treatment: patient or physician? Elisa Hurley, a philosophy professor, is seeking answers to these questions in her research currently underway at The Read more…
For many of the nation’s 40 million contact lens wearers, seasonal ocular allergy symptoms such as itching, tearing, and redness caused by contact lens wear, often hit them during the time that they want to be wearing their lenses for outdoor sports, exercise, and socializing. This increase in incidences of lens discomfort causes many to use rewetting drops more often, wear their lenses less frequently, or switch back to glasses.
But, according to most eye Read more…
The US Food and Drug Administration (FDA) has received reports of sudden reduction or loss of hearing following the use of PDE5 inhibitors, a class of drugs
that includes the erectile dysfunction (ED) medications Viagra, Levitra, and Cialis and also Revatio, used to treat pulmonary arterial hypertension
(PAH).
The FDA has approved manufacturers’ label changes for the ED drugs that highlight this risk more prominently and advise Read more…
Chelsea and Westminster Hospital NHS Foundation Trust becomes the
first NHS body to venture into online treatment by launching a remote
treatment service for erectile dysfunction in partnership with DrThom
(), the UK’s leading online healthcare provider.
Chelsea and Westminster and DrThom will make it easier for the 2.3 million
UK Read more…
St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder.
Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after the procedure, 56 percent of the patients experienced at least a 40 percent decrease in Read more…
Intra-Cellular Therapies, Inc., announced additional preclinical data from its ongoing development
programs for ITI-007, the Company’s first-in-class dual 5HT2A receptor
antagonist/dopamine receptor phosphoprotein modulator (DPPM), and ITI-722,
a low-dose formulation of ITI-007, which are in development for
schizophrenia and sleep disorders, respectively. These new data demonstrate
ITI-007 has preclinical activity both in Read more…
Alzheimer’s disease may be what most people fear as they grow older, but autopsy data from a long-range study of 3,400 men and women in the Seattle region found that the brains of a third of those who had become demented before death showed evidence of small vessel damage: the type of small, cumulative injury that can come from hypertension or diabetes.
Dr. Thomas Montine, University of Washington, presented the study results at Read more…